WHO ICTRP trial
SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in…
EUCTR2018-000727-13-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2018-000727-13-BE |
|---|---|
| Public title | SOLAR: Efficacy and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects with Mycosis Fungoides |
| Scientific title | SOLAR: A Phase 2, Randomized, Open-label, Parallel-group, Active Comparator, Multi-center Study to Investigate the Efficacy and Safety of Cobomarsen (MRG-106) in Subjects with Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides (MF) Subtype - SOLAR |
| Primary sponsor | miRagen Therapeutics, Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;France;Canada;Spain;Belgium;Austria;Australia;Netherlands;Germany;United Kingdom;Italy |
| Conditions | Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides (MF) Subtype MedDRA version: 20.0 Level: PT Classification code 10028483 Term: Mycosis fungoides System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and… |
| Interventions | Product Name: cobomarsen Product Code: MRG-106 Pharmaceutical Form: Solution for infusion INN or Proposed INN: COBOMARSEN CAS Number: 1848257-52-2 Current Sponsor code: MRG-106 Concentration unit: mg/ml milligram(s)/millilitre Concentration… |
| Registration date | Aug 23, 2018 |
| Target size | 126 |
| Secondary IDs | MRG106-11-201;2018-000727-13-GB |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: